CARDIFF ONCOLOGY INC (CRDF) Stock Balance Sheet
NASDAQ:CRDF - Nasdaq - US14147L1089 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 24.09M | 51.47M | 21.66M | 16.30M | 11.90M | |||
| Marketable Securities | 55.79M | 40.28M | 53.17M | 88.90M | 128.90M | |||
| Receivables | 405.00K | 1.17M | 888.00K | 800.00K | 500.00K | |||
| Other Current Assets | 2.42M | 2.13M | 1.70M | 5.20M | 4.80M | |||
| Total Current Assets | 82.71M | 95.05M | 77.41M | 111.30M | 146.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.84M | 2.07M | 2.95M | 3.50M | 3.20M | |||
| Other Non-Current Assets | 257.00K | 69.00K | 1.28M | 1.40M | 200.00K | |||
| Total Non-Current Assets | 2.10M | 2.14M | 4.22M | 4.90M | 3.40M | |||
| TOTAL ASSETS | 84.81M | 97.19M | 81.64M | 116.20M | 149.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 9.66M | 8.61M | 8.47M | 5.70M | 4.50M | |||
| Accounts Payable | 3.63M | 4.82M | 1.97M | 2.00M | 1.40M | |||
| Other Current Liabilities | N/A | N/A | N/A | 100.00K | 600.00K | |||
| Total Current Liabilities | 13.29M | 13.43M | 10.44M | 7.80M | 6.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 640.00K | 813.00K | 1.46M | 2.00M | 2.60M | |||
| Total Non-Current Liabilities | 640.00K | 813.00K | 1.46M | 2.00M | 2.50M | |||
| TOTAL LIABILITIES | 13.93M | 14.24M | 11.90M | 9.80M | 9.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -397.61M | -384.18M | -339.54M | -298.10M | -259.80M | |||
| Additional Paid In Capital | 468.45M | 467.09M | 409.34M | 404.80M | 400.50M | |||
| Common Shares | 7.00K | 7.00K | 4.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 27.00K | 34.00K | -67.00K | -400.00K | -300.00K | |||
| Shares Outstanding | 66.53M | 66.52M | 44.68M | 44.70M | 42.00M | |||
| Tangible Book Value per Share | 1.07 | 1.25 | 1.56 | 2.38 | 3.34 | |||
| Total Shareholders' Equity | 70.88M | 82.95M | 69.74M | 106.30M | 140.40M | |||
| TOTAL LIABILITIES AND EQUITY | 84.81M | 97.19M | 81.64M | 116.20M | 149.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 6.22 | 7.08 | 7.41 | 14.27 | 22.14 | |||
| Return On Assets (ROA) | -57.63% | -46.77% | -50.79% | -33.33% | -18.94% | |||
| Return On Equity (ROE) | -68.96% | -54.80% | -59.46% | -36.43% | -20.17% | |||
All data in USD , ROIC based on taxRate of 0.21